References
- Bickers DR, Pathak MA, Lim HW. The porphyrias. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. 4th ed. New York: McGraw-Hill, Health Professions Division, 1993: 1854–93
- Kutz DC, Bridges AJ. Bullous rash and brown urine in a systemic lupus erythematosus patient treated with hydroxychloroquine. Arthritis Rheum 1995; 38(3): 440–3
- Liu AC. Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda. West J Med 1995; 162(6): 548–51
- Daw H, Isaacson JH. A 52-year-old woman with skin lesions and liver function abnormalities. Cleve Clin J Med 1997; 64(10): 520–2
- Krauss GL, Simmons-O'Brien E, Campbell M. Successful treatment of seizures and porphyria with gabapentin. Neurology 1995; 45(3 Pt 1): 594–5
- Tatum WO 4th, Zachariah SB. Gabapentin treatment of seizures in acute intermittent porphyria. Neurology 1995; 45(6): 1216–7
- Leo RJ, Cannuli AR. Porphyria cutanea tarda associated with carbamazepine treatment. Am J Psychiatry 1996; 153(3): 443–4
- McAlister F, McClean K, Hamilton PG, et al. Human immunodeficiency virus infection and porphyria cutanea tarda: coexistence of risk factors or causative association? Clin Infect Dis 1995; 20(2): 348–51
- Cribier B, Petiau P, Keller F, et al. Porphyria cutanea tarda and hepatitis C viral infection: a clinical and virologie study. Arch Dermatol 1995; 131(7): 801–4